Add Formweb to your mobile device
Search results for:
talquetamab
talquetamab
Brand names: Talvey
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOLUTION, SUBCUTANEOUS | tgvs 2 mg/mL; tgvs 40 mg/mL |
Last updated: Dec. 9, 2024
talquetamab
| Form | Strength | ANAN | ASMP | LACH | LALK | LOHH | LOLR | LOWC | SDSD | SESE | SFSF | Formulary Status |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOLUTION, SUBCUTANEOUS | tgvs 2 mg/mL; tgvs 40 mg/mL |
Due to risk of CRS and neurologic toxicity, patients should be hospitalized for 48 hours after all doses within the talquetamab step-up dosing schedule.